Our study demonstrated that, among patients with initially unresectable mCRC who became eligible for conversion surgery after neoadjuvant therapy, those treated with adjuvant CT plus TA showed a trend toward longer survival than those receiving adjuvant CT alone.
← all excerpts
Assessing the effectiveness of targeted agents in adjuvant therapy for patients with metastatic colorectal cancer undergoing surgical resection: a retrospective cohort study.
1
—
—